Via Nova Therapeutics Inc
Guardat en:
| Publicat a: | GlobalData Deals and Alliances Profiles (2025) |
|---|---|
| Publicat: |
GlobalData plc
|
| Matèries: | |
| Accés en línia: | Citation/Abstract Full Text - PDF |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
MARC
| LEADER | 00000nab a2200000uu 4500 | ||
|---|---|---|---|
| 001 | 3158368146 | ||
| 003 | UK-CbPIL | ||
| 035 | |a 3158368146 | ||
| 045 | 2 | |b d20250101 |b d20251231 | |
| 084 | |a 165128 |2 nlm | ||
| 245 | 1 | |a Via Nova Therapeutics Inc | |
| 260 | |b GlobalData plc |c 2025 | ||
| 513 | |a Company Report | ||
| 520 | 3 | |a Via Nova Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile Via Nova Therapeutics Inc (Via Nova) is a biotechnology company that develops therapies for the treatment of viral diseases. The company's lead product candidate, VNT-101, is a small molecule to treat influenza A infection. Its lead products have demonstrated activity in vitro against seasonal influenza A and highly pathogenic avian influenza (HPAI) H5N1 and H7N9 strains. Via Nova Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. | |
| 610 | 4 | |a Via Nova Therapeutics Inc | |
| 651 | 4 | |a United States--US | |
| 653 | |a Corporate profiles | ||
| 653 | |a Statistical data | ||
| 653 | |a Securities analysis | ||
| 653 | |a Health care industry | ||
| 653 | |a Acquisitions & mergers | ||
| 773 | 0 | |t GlobalData Deals and Alliances Profiles |g (2025) | |
| 786 | 0 | |d ProQuest |t ABI/INFORM Trade & Industry | |
| 856 | 4 | 1 | |3 Citation/Abstract |u https://www.proquest.com/docview/3158368146/abstract/embedded/6A8EOT78XXH2IG52?source=fedsrch |
| 856 | 4 | 0 | |3 Full Text - PDF |u https://www.proquest.com/docview/3158368146/fulltextPDF/embedded/6A8EOT78XXH2IG52?source=fedsrch |